Brief: Cellbxhealth Signs New Statement Of Work With US-Based Pharma Company
14/10/2026 07:21
BRIEF-Cellbxhealth Signs New Statement Of Work With US-Based Pharma Company Oct 14 (Reuters) - Cellbxhealth PLC CLBX.L:
CELLBXHEALTH PLC - NEW STATEMENT OF WORK WITH US-BASED PHARMA COMPANY
CELLBXHEALTH - STATEMENT OF WORK VALUED AT ABOUT $65,000 FOR 100 PATIENT SAMPLES
Source text: ID:nRSN8234Ya
Further company coverage: CLBX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cellbxhealth
See all newsBrief: Cellbxhealth Anticipates FY2027 Revenues Of £3 Million-£4 Million
Brief: Cellbxhealth Enters Master Services Agreement With Swiss Biotech
Master Services Agreement with Swiss biotech co
Q3 Trading Update and FY 2026 Outlook
Brief: Cellbxhealth Signs New Statement Of Work With US-Based Pharma Company